BioNTech Initiates Phase 1 Clinical Trial for Malaria

BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention based on a novel multi-antigen vaccine approachFirst evaluated candidate...

Related Keywords

Germany ,Rwanda ,United States ,Kigali ,W09 ,Sylke Maas ,Fosun Pharma ,Pfizer ,Genentech ,World Health Organization ,Roche Group ,Africa Centers For Disease ,Company Malaria ,Africa Centers ,Disease Control ,Chief Medical Officer ,New Technologies ,Private Securities Litigation Reform Act ,Quarterly Report ,Nasdaq Bntx ,Biontech Se ,Ntx ,Malaria ,Mrna Vaccine ,Africa Cdc ,Nt165 ,Mrna Impfstoffe ,Frika Cdc ,